Pharmaceutical Export to Kuwait from India

Kuwait is a significant pharmaceutical market in the Gulf region, with substantial imports of finished pharmaceutical products from international manufacturers. In 2025, Kuwait imported approximately US$2.59 billion of pharmaceutical products under HS Chapter 30. India supplied approximately US$19.48 million of these pharmaceutical imports, while India reported pharmaceutical exports to Kuwait of approximately US$12.19 million for the same year.

Global Entra Pharma is an Indian pharmaceutical manufacturer supplying finished pharmaceutical products to international markets, including specialized dosage forms such as suppositories, pessaries, vaginal ovules, pharmaceutical creams and ointments.

Pharmaceutical Manufacturer in India for Kuwait

Global Entra Pharma manufactures finished pharmaceutical products in India for international pharmaceutical markets.

Our manufacturing capabilities can support:

• Finished pharmaceutical formulations

• Suppositories

• Pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

• Private-label pharmaceutical manufacturing

• Contract manufacturing

• Bulk pharmaceutical manufacturing

• Customized pharmaceutical packaging

• Export-oriented production

Product availability and manufacturing feasibility depend on the formulation, strength, dosage form and applicable regulatory requirements.

Pharmaceutical Products Manufactured for Kuwait

Global Entra Pharma manufactures pharmaceutical products according to approved formulations and applicable manufacturing specifications.

Our specialized dosage-form portfolio includes:

• Pharmaceutical suppositories

• Vaginal pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

Other pharmaceutical dosage forms can also be considered according to manufacturing capability and product requirements.

Suppository Manufacturer in India for Kuwait

Global Entra Pharma manufactures pharmaceutical suppositories for international markets.

Suppositories may be manufactured for appropriate therapeutic applications such as:

• Pain and inflammation

• Haemorrhoidal conditions

• Women's healthcare

• Local therapeutic applications

• Other approved pharmaceutical indications

Strength, formulation, packaging, specifications and shelf life depend on the individual product.

Pessary Manufacturer in India for Kuwait

Global Entra Pharma manufactures specialized pharmaceutical pessaries for vaginal administration.

Potential product categories include:

• Antifungal pessaries

• Antimicrobial pessaries

• Women's healthcare formulations

• Other vaginal pharmaceutical preparations

Products are manufactured according to the approved composition, specifications and applicable regulatory requirements.

Vaginal Ovule Manufacturer in India for Kuwait

Global Entra Pharma manufactures vaginal ovule formulations for international pharmaceutical markets.

Vaginal ovules can be manufactured with suitable active pharmaceutical ingredients and pharmaceutical excipients for approved applications.

Potential applications include:

• Women's healthcare

• Vaginal therapeutic products

• Local antimicrobial formulations

• Other approved vaginal pharmaceutical preparations

Pharmaceutical Cream Manufacturer in India for Kuwait

Global Entra Pharma manufactures pharmaceutical creams for topical and dermatological applications.

Our pharmaceutical cream manufacturing portfolio can include:

• Antifungal creams

• Antibacterial creams

• Anti-inflammatory creams

• Dermatological creams

• Combination creams

• Moisturizing pharmaceutical formulations

• Other topical preparations

Creams can be manufactured in suitable packaging formats according to product requirements.

Pharmaceutical Ointment Manufacturer in India for Kuwait

Global Entra Pharma manufactures pharmaceutical ointments for topical applications.

Ointment manufacturing can include formulations for:

• Dermatological applications

• Antibacterial applications

• Anti-inflammatory applications

• Protective topical applications

• Other approved pharmaceutical uses

The final composition, packaging and specifications are determined according to the individual pharmaceutical product.

Five Specialized Pharmaceutical Dosage Forms

Global Entra Pharma focuses on specialized dosage-form manufacturing for international markets.

1. Suppositories

Solid pharmaceutical preparations designed for appropriate administration through body cavities.

2. Pessaries

Specialized vaginal dosage forms used for local pharmaceutical administration.

3. Vaginal Ovules

Vaginal pharmaceutical preparations manufactured using appropriate active ingredients and excipients.

4. Pharmaceutical Creams

Topical semisolid formulations used for suitable dermatological and pharmaceutical applications.

5. Pharmaceutical Ointments

Semisolid topical pharmaceutical preparations manufactured for appropriate therapeutic applications.

Pharmaceutical Market in Kuwait

Kuwait has a substantial pharmaceutical import market. According to World Bank WITS, total pharmaceutical imports reached approximately US$2.59 billion in 2025. The United States, Germany, Switzerland, Italy and France were among the leading suppliers, while India supplied approximately US$19.48 million.

This established import market provides opportunities for qualified pharmaceutical manufacturers supplying appropriately registered products through Kuwait's pharmaceutical regulatory and distribution system.

Pharmaceutical Registration in Kuwait

Pharmaceutical product registration in Kuwait is administered through the Ministry of Health and its relevant pharmaceutical and drug-control departments.

Kuwait's Ministry of Health pharmaceutical registration guidance identifies requirements for both the local agent and the Marketing Authorization Holder (MAH), including documentation relating to the local pharmaceutical company, manufacturing authorization and manufacturing sites.

The specific registration requirements depend on the pharmaceutical product and applicable regulatory category.

Drug Registration Requirements in Kuwait

The requirements for pharmaceutical registration can include:

• Local agent documentation

• Marketing Authorization Holder information

• Manufacturing licence

• Manufacturing-site information

• GMP certificate

• Product technical documentation

• Pharmaceutical composition

• Manufacturing information

• Quality specifications

• Stability information

• Product packaging

• Certificate of Analysis

• CPP where applicable

• Free Sale Certificate where applicable

• Samples where required

Kuwait's Ministry of Health guidance states that a new local pharmaceutical company acting as a local agent may need a Ministry of Commerce licence covering medicine sales, a Drug Inspection Administration licence and a valid store licence.

Local Pharmaceutical Agent in Kuwait

A local pharmaceutical agent is an important part of the registration and import structure for pharmaceutical products.

Kuwait's Ministry of Health guidance requires documentation concerning the local agent during pharmaceutical product registration. It also identifies an appointment letter from the Marketing Authorization Holder establishing the relationship with the local agent.

The local company must satisfy the applicable licensing and pharmaceutical storage requirements in Kuwait.

Marketing Authorization Holder and Manufacturer

Kuwait's pharmaceutical registration framework distinguishes between the Marketing Authorization Holder and manufacturing site where applicable.

For manufacturing sites, the Ministry of Health guidance identifies requirements including:

• Manufacturing licence from the country of origin

• GMP documentation

• Manufacturing-site information

• Legalized documentation where applicable

Where the manufacturer differs from the MAH, the regulatory documentation should establish the relationship between the parties.

Global Entra Pharma can provide applicable manufacturing documentation for its pharmaceutical products.

Pharmaceutical Dossier for Kuwait

A pharmaceutical registration dossier may include:

• Administrative information

• Applicant information

• Manufacturer information

• Product composition

• Manufacturing process

• Pharmaceutical development

• Quality specifications

• Analytical methods

• Validation documentation

• Stability data

• Packaging information

• Finished-product information

• GMP documentation

• Manufacturing licence

• CPP

• Free Sale Certificate where applicable

• Product artwork

• Package insert

• Samples

The final dossier requirements should be confirmed according to the current Kuwait regulatory pathway for the specific product.

GMP Requirements for Pharmaceutical Export to Kuwait

GMP compliance is an important part of pharmaceutical manufacturing and regulatory review.

Kuwait's Ministry of Health guidance identifies GMP certification among the documentation that may be required for manufacturing-site registration. The Ministry may also request a GMP inspection visit for a manufacturing site.

Global Entra Pharma can provide applicable manufacturing-site documentation, including:

• GMP certificate

• Manufacturing licence

• Manufacturing-site information

• Quality documentation

• Product specifications

• Analytical documentation

• Stability information

The exact GMP requirements should be verified for the product and registration pathway.

Certificate of Pharmaceutical Product for Kuwait

A Certificate of Pharmaceutical Product (CPP) may be required as part of pharmaceutical registration depending on the product and regulatory pathway.

Where applicable, the CPP should be issued by the competent authority and provided according to Kuwait's current documentation and legalization requirements.

Free Sale Certificate for Kuwait

A Free Sale Certificate may be required for certain pharmaceutical products or regulatory pathways.

The requirement should be confirmed for the individual product before preparation of the registration dossier.

Where applicable, the certificate should be appropriately issued, authenticated and legalized according to the current requirements.

Manufacturing Licence from India

The pharmaceutical manufacturing site should hold the appropriate manufacturing authorization in India.

Documentation may include:

• Manufacturing licence

• GMP certificate

• Manufacturing-site details

• Product-related approvals

• Quality-control documentation

• Product specifications

Kuwait's pharmaceutical registration guidance specifically identifies an original legalized manufacturing licence from the country of origin for each manufacturing site.

Pharmaceutical Import Requirements in Kuwait

Kuwait operates an import licensing system, and pharmaceuticals are among the products subject to specific licensing requirements. The U.S. International Trade Administration notes that specific ministries and agencies issue licences for products including pharmaceuticals and that local agents are authorized to clear certain goods through Kuwait Customs.

For pharmaceutical shipments, the importer should ensure that all applicable:

• Import licences

• Pharmaceutical registrations

• Agent requirements

• Customs documents

• Product approvals

• Shipping documents

are completed before shipment.

Pharmaceutical Customs Documents for Kuwait

Commercial shipments to Kuwait generally require documentation such as:

• Commercial invoice

• Certificate of origin

• Packing list

• Bill of lading or airway bill

Additional pharmaceutical licences and certificates may be required depending on the product.

The pharmaceutical importer should confirm the final shipment documentation before dispatch.

Stability Data for Pharmaceutical Products

Stability data supports the proposed shelf life and storage conditions of pharmaceutical products.

Depending on the product, stability documentation can include:

• Long-term stability data

• Accelerated stability data

• Stability protocol

• Testing intervals

• Storage conditions

• Stability specifications

• Shelf-life justification

The applicable requirements should be determined for each product during regulatory preparation.

Certificate of Analysis

The Certificate of Analysis provides quality-control results for a pharmaceutical batch.

Depending on the product, a CoA can contain:

• Product name

• Batch number

• Manufacturing date

• Expiry date

• Appearance

• Identification

• Assay

• Related substances

• Microbiological tests

• Product-specific tests

• Specification

• Test results

The CoA should correspond to the approved product specifications and manufactured batch.

Pharmaceutical Packaging for Kuwait

Packaging should comply with the approved pharmaceutical product information and applicable Kuwait requirements.

Global Entra Pharma can manufacture pharmaceutical products in packaging formats such as:

• Blister packs

• Strips

• Tubes

• Jars

• Cartons

• Sachets

• Other product-specific packaging

Final artwork and labelling should be reviewed according to the applicable regulatory requirements before production.

Private Label Pharmaceutical Manufacturing for Kuwait

Global Entra Pharma provides private-label pharmaceutical manufacturing for qualified international pharmaceutical companies and distributors.

Private-label manufacturing can include:

• Pharmaceutical formulation

• Product manufacturing

• Brand-specific packaging

• Carton artwork

• Labels

• Batch production

• Quality testing

• Export documentation

Private-label projects remain subject to product feasibility and applicable Kuwait registration requirements.

Contract Pharmaceutical Manufacturing for Kuwait

Global Entra Pharma can manufacture pharmaceutical products under contract manufacturing arrangements for international pharmaceutical companies.

Contract manufacturing can cover:

• Suppositories

• Pessaries

• Vaginal ovules

• Creams

• Ointments

• Existing formulations

• Customized formulations

• Private-label products

• Bulk pharmaceutical products

The manufacturing agreement should clearly define responsibilities for product registration, manufacturing, quality control, packaging and market authorization.

Bulk Pharmaceutical Manufacturing for Kuwait

Global Entra Pharma can manufacture pharmaceutical products for bulk orders according to agreed product specifications.

Commercial discussions can include:

• Product

• Strength

• Dosage form

• Quantity

• Packaging

• MOQ

• Shelf life

• Delivery terms

• Payment terms

• Regulatory documentation

Bulk supply is subject to manufacturing capacity, product requirements and applicable Kuwait regulations.

Quality Control for Pharmaceutical Export to Kuwait

Quality control is an essential component of pharmaceutical manufacturing.

Depending on the formulation, quality documentation can include:

• Raw-material specifications

• Finished-product specifications

• Analytical methods

• Batch testing

• Certificate of Analysis

• Microbiological testing

• Stability studies

• Packaging specifications

• Manufacturing records

Global Entra Pharma manufactures finished pharmaceutical products according to applicable product specifications and quality requirements.

Why Choose an Indian Pharmaceutical Manufacturer?

India has a large pharmaceutical manufacturing industry with extensive international export experience.

Advantages for international pharmaceutical buyers can include:

• Competitive manufacturing economics

• Established pharmaceutical manufacturing infrastructure

• Generic pharmaceutical expertise

• Specialized dosage-form manufacturing

• Flexible packaging options

• Private-label manufacturing

• Contract manufacturing

• International export experience

• Pharmaceutical documentation capabilities

India exported approximately US$25.89 billion of pharmaceutical products worldwide in 2025 under HS Chapter 30, according to World Bank WITS.

Global Entra Pharma – Pharmaceutical Manufacturer for Kuwait

Global Entra Pharma is an Indian pharmaceutical manufacturer supplying finished pharmaceutical products to international markets.

Our specialized pharmaceutical manufacturing portfolio includes:

• Suppositories

• Pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

Global Entra Pharma also supports private-label and contract manufacturing requirements for qualified international pharmaceutical companies.

For Kuwait, products can be manufactured and supplied according to agreed specifications and applicable regulatory requirements.

Pharmaceutical Manufacturing and Export Process

Step 1 – Product Requirement

The buyer provides:

• Product name

• Strength

• Dosage form

• Quantity

• Packaging requirement

Step 2 – Manufacturing Evaluation

Global Entra Pharma evaluates manufacturing feasibility, formulation requirements and product specifications.

Step 3 – Commercial Quotation

The quotation can be prepared based on:

• Product

• Strength

• Quantity

• Packaging

• MOQ

• Delivery terms

Step 4 – Regulatory Documentation

Applicable manufacturing and product documents are prepared for regulatory review.

Step 5 – Product Registration

Where required, the Kuwait-based applicant proceeds with the applicable pharmaceutical registration process.

Step 6 – Manufacturing

Following completion of the required commercial and regulatory steps, production is carried out according to the agreed specifications.

Step 7 – Quality Testing

The finished pharmaceutical batch undergoes applicable quality-control testing.

Step 8 – Export Documentation

Commercial, quality and shipping documentation is prepared.

Step 9 – Shipment to Kuwait

The finished pharmaceutical products are shipped according to the agreed commercial terms and applicable Kuwait import requirements.

How to Buy Pharmaceutical Products from India for Kuwait

Kuwait-based pharmaceutical companies, importers, distributors and marketing companies can contact Global Entra Pharma with their pharmaceutical manufacturing requirements.

For a quotation, provide:

• Product name

• Strength

• Dosage form

• Required quantity

• Packaging

• Private-label requirement

• Required documentation

• Registration status, if applicable

Global Entra Pharma can evaluate the manufacturing requirement and provide a commercial quotation.

FAQs – Pharmaceutical Export to Kuwait from India

Is India a pharmaceutical supplier to Kuwait?

Yes. India supplied approximately US$19.48 million of pharmaceutical products to Kuwait in 2025 according to Kuwait's reported import data in World Bank WITS.

How large is Kuwait's pharmaceutical import market?

Kuwait reported approximately US$2.59 billion in pharmaceutical imports in 2025 under HS Chapter 30.

Who regulates pharmaceutical products in Kuwait?

Pharmaceutical products are regulated through Kuwait's Ministry of Health and its relevant pharmaceutical and drug-control departments.

Is pharmaceutical registration required in Kuwait?

Pharmaceutical products intended for the Kuwait market are subject to applicable registration and regulatory requirements.

Is a local pharmaceutical agent required?

Kuwait's pharmaceutical registration guidance contains specific local-agent requirements, including licensing and pharmaceutical-storage documentation.

Does Kuwait require GMP documentation?

GMP documentation is part of the manufacturing-site registration requirements identified by Kuwait's Ministry of Health. A GMP inspection may also be requested for a manufacturing site.

Can Global Entra Pharma manufacture pharmaceutical products for Kuwait?

Yes. Global Entra Pharma is an Indian pharmaceutical manufacturer supplying finished pharmaceutical products to international markets, subject to product availability and applicable regulatory requirements.

Does Global Entra Pharma manufacture suppositories?

Yes. Suppositories are among the specialized pharmaceutical dosage forms manufactured for international markets.

Does Global Entra Pharma manufacture pessaries and vaginal ovules?

Yes. Pessaries and vaginal ovules can be manufactured according to the required formulation, specifications and applicable regulatory pathway.

Can Global Entra Pharma manufacture pharmaceutical creams and ointments?

Yes. Pharmaceutical creams and ointments are part of the specialized topical dosage-form manufacturing portfolio.

Can Global Entra Pharma manufacture private-label pharmaceutical products?

Yes. Private-label pharmaceutical manufacturing can be considered for suitable products and qualified international buyers.

Can Global Entra Pharma manufacture pharmaceutical products in bulk?

Yes. Bulk manufacturing can be considered according to MOQ, quantity, packaging, manufacturing capacity and product specifications.

Request Pharmaceutical Manufacturing for Kuwait

Global Entra Pharma welcomes inquiries from Kuwait-based pharmaceutical companies, importers, distributors and marketing companies seeking pharmaceutical manufacturing from India.

Send:

• Product name

• Strength

• Dosage form

• Quantity

• Packaging requirement

• Private-label requirement

• Required regulatory documents

Global Entra Pharma can evaluate the requirement and provide a manufacturing quotation based on the requested product specifications.